Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-6499-12 proof-of-principle study in constipation-predominant irritable bowel syndrome
2010-018902-35Phase 2Completed
- Sponsor
- Targacept
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing TC-6499-12 with Placebo (2 arms). Primary endpoint: Global symptom relief on Day 29. Started Mar 2010; status: completed.
02
Drugs
simpinicline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2010-018902-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018902-35.